Cobicistat: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption=' | <StructureSection load='' size='340' side='right' caption='Cobicistat' scene='98/989322/Cv/1'> | ||
Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | ||
<scene name='98/989322/Cv/2'>Complex of CYP3A4 with a desoxyritonavir analog</scene> ([[4k9t]]). | <scene name='98/989322/Cv/2'>Complex of CYP3A4 with a desoxyritonavir analog</scene> ([[4k9t]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||